-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Have AdaptHealth Corp. (NASDAQ:AHCO) Insiders Been Selling Their Stock?
Have AdaptHealth Corp. (NASDAQ:AHCO) Insiders Been Selling Their Stock?
We wouldn't blame AdaptHealth Corp. (NASDAQ:AHCO) shareholders if they were a little worried about the fact that Wayne Quasha, a company insider, recently netted about US$4.0m selling shares at an average price of US$20.00. However, it's crucial to note that they remain very much invested in the stock and that sale only reduced their holding by 1.4%.
See our latest analysis for AdaptHealth
The Last 12 Months Of Insider Transactions At AdaptHealth
Notably, that recent sale by insider Wayne Quasha was not the only time they sold AdaptHealth shares this year. They previously made an even bigger sale of -US$18m worth of shares at a price of US$21.50 per share. That means that even when the share price was slightly below the current price of US$21.72, an insider wanted to cash in some shares. When an insider sells below the current price, it suggests that they considered that lower price to be fair. That makes us wonder what they think of the (higher) recent valuation. Please do note, however, that sellers may have a variety of reasons for selling, so we don't know for sure what they think of the stock price. This single sale was just 5.8% of Wayne Quasha's stake.
Happily, we note that in the last year insiders paid US$524k for 33.93k shares. On the other hand they divested 2.30m shares, for US$49m. All up, insiders sold more shares in AdaptHealth than they bought, over the last year. The chart below shows insider transactions (by companies and individuals) over the last year. By clicking on the graph below, you can see the precise details of each insider transaction!
I will like AdaptHealth better if I see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.
Insider Ownership Of AdaptHealth
Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. I reckon it's a good sign if insiders own a significant number of shares in the company. AdaptHealth insiders own 18% of the company, currently worth about US$525m based on the recent share price. Most shareholders would be happy to see this sort of insider ownership, since it suggests that management incentives are well aligned with other shareholders.
So What Does This Data Suggest About AdaptHealth Insiders?
Insiders sold AdaptHealth shares recently, but they didn't buy any. Despite some insider buying, the longer term picture doesn't make us feel much more positive. But since AdaptHealth is profitable and growing, we're not too worried by this. While insiders do own a lot of shares in the company (which is good), our analysis of their transactions doesn't make us feel confident about the company. While we like knowing what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. Every company has risks, and we've spotted 3 warning signs for AdaptHealth (of which 1 is a bit concerning!) you should know about.
Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
我們不會責怪AdaptHealth Corp.納斯達克(Sequoia Capital:AHCO)股東如果對公司內部人士韋恩·誇沙最近以平均20美元的價格出售股票淨賺約400萬美元感到有點擔憂。然而,重要的是要注意到,他們仍然非常多地投資於股票,出售只減少了1.4%的持有量。
查看我們對AdaptHealth的最新分析
AdaptHealth最近12個月的內幕交易
值得注意的是,內部人士韋恩·誇沙最近的出售並不是他們今年唯一次出售AdaptHealth股票。此前,他們以每股21.5美元的價格出售了價值1800萬美元的股票,規模更大。這意味著,即使股價略低於目前21.72美元的價格,一名內部人士也想套現一些股票。當內部人士以低於當前價格的價格出售股票時,這表明他們認為較低的價格是公平的。這讓我們想知道他們對最近(較高的)估值有何看法。然而,請注意,賣家可能有各種各樣的理由出售,所以我們不能確切地知道他們對股價的看法。這筆交易僅佔韋恩·誇沙所持股份的5.8%。
令人高興的是,我們注意到,在去年,內部人士支付了52.4萬美元購買了339.3萬股。另一方面,他們以4900萬美元的價格剝離了230萬股票。總而言之,在過去一年裡,內部人士賣出的AdaptHealth股票多於他們購買的股票。下面的圖表顯示了過去一年的內幕交易(按公司和個人)。通過點擊下面的圖表,你可以看到每一筆內幕交易的準確細節!
如果我看到一些內部人士大舉收購,我會更喜歡AdaptHealth。在我們等待的時候,看看這個免費最近有大量內幕收購的成長型公司名單。
AdaptHealth的內部所有權
看看一家公司的內部人持股總數,可以幫助你瞭解他們是否與普通股股東很好地結合在一起。我認為,如果內部人士持有該公司大量股份,這是一個好兆頭。AdaptHealth內部人士擁有該公司18%的股份,根據最近的股價,目前價值約為5.25億美元。大多數股東將樂於看到這種內部人持股,因為這表明管理層的激勵與其他股東很好地結合在一起。
那麼,這些數據對AdaptHealth內部人士有什麼啟示呢?
內部人士最近拋售了AdaptHealth的股票,但他們沒有買入任何股票。儘管有一些內部人士買入,但更長期的前景並沒有讓我們感覺更積極。但由於AdaptHealth是盈利的,而且還在增長,我們並不太擔心這一點。雖然內部人士確實持有該公司的大量股份(這很好),但我們對他們交易的分析並不能讓我們對該公司充滿信心。雖然我們喜歡知道內部人士的所有權和交易情況,但在做出任何投資決定之前,我們也要確保考慮到一隻股票面臨的風險。每家公司都有風險,我們已經發現AdaptHealth的3個警告標誌(其中1個有點令人擔憂!)你應該知道。
當然了,如果你把目光投向別處,你可能會發現這是一筆很棒的投資。所以讓我們來看看這個免費有趣的公司名單。
就本文而言,內部人是指向相關監管機構報告其交易的個人。我們目前負責公開市場交易和私人處置,但不包括衍生品交易。
對這篇文章有什麼反饋嗎?擔心內容嗎?保持聯繫直接與我們聯繫。或者,也可以給編輯組發電子郵件,地址是implywallst.com。
本文由Simply Wall St.撰寫,具有概括性。我們僅使用不偏不倚的方法提供基於歷史數據和分析師預測的評論,我們的文章並不打算作為財務建議。它不構成買賣任何股票的建議,也沒有考慮你的目標或你的財務狀況。我們的目標是為您帶來由基本面數據驅動的長期重點分析。請注意,我們的分析可能不會將最新的對價格敏感的公司公告或定性材料考慮在內。Simply Wall St.對上述任何一隻股票都沒有持倉。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧